| Aggressive Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 130show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 119 trials (42 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 119 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 91 trials (24 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 91 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 66 trials (22 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 65 trials (20 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 60 trials (15 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 60 trials (27 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 59 trials (23 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 35 trials (10 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 33 trials (12 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 32 trials (11 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 32 trials (11 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 22 trials (8 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 19 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 17 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 17 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |